Stocky
ALVO
Alvotech
NASDAQ NMS - GLOBAL MARKET · Biotechnology · LU
3.76
▼ -2.08%

What's happening at Alvotech

Alvotech's latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 16 Jun 2026

Raises $85 million selling 22.7 million shares to investors

The company is getting fresh money by selling new shares, which increases total shares outstanding and can dilute existing investors.

SEC 424B5 · filed 2026-06-16 View filing ↗
Deal 15 Jun 2026

Plans concurrent private placement in European Economic Area

Additional share sale to European investors shows the company is raising capital from multiple sources to fund operations.

SEC 424B5 · filed 2026-06-15 View filing ↗

Common questions

How does Stocky track Alvotech's company events?

Stocky reads Alvotech's official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Alvotech's most recent SEC filing?

Alvotech's most recent tracked filing was a 424B5 on 16 Jun 2026: Raises $85 million selling 22.7 million shares to investors.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Alvotech's full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.